← Open Payments lookup

NICHOLAS AUSTIN: Open Payments

NPI 1063069383 · LONGVIEW, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,732 in 86 payments from 25 companies in 2025. Trend: 2023 $985 · 2024 $1,692 · 2025 $1,732

Food & beverage: $1,711Education: $21
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP11$222
Amgen Inc.11$210
Novartis Pharmaceuticals Corporation7$194
GlaxoSmithKline, LLC.10$153
Salix Pharmaceuticals, a division of Bausch Health US, LLC6$101
Bayer Healthcare Pharmaceuticals Inc.5$98
Corcept Therapeutics4$94
PFIZER INC.4$88
ABBVIE INC.4$84
Actelion Pharmaceuticals US, Inc.3$72

Products named: LEQVIO, EVENITY, TRELEGY ELLIPTA, AIRSUPRA, XIFAXAN, Kerendia, Korlym, REXULTI.

Industry payments across WA — which companies pay providers there.